Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Reilly

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
British Journal of Haematology|March 11, 2004
Mutations in PTPN11 are uncommon in adult myelodysplastic syndromes and acute myeloid leukaemiaM F Johan, D T Bowen, M E Frew, et al.
British Journal of Haematology|June 19, 2001
Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patientsE Matutes, G P Taylor, J Cavenagh, et al.
Journal of Immunological Methods|January 4, 2005
Evaluation of leukocyte stabilisation in TransFix-treated blood samples by flow cytometry and transmission electron microscopyB Canonico, L Zamai, S Burattini, et al.
Hemoglobin|September 26, 2001
A second case of Hb Renert [beta133(H11)Val --> Ala]G Wilson, P Forrest, S Heppinstall, et al.
Clinical and Laboratory Haematology|May 3, 2000
Standardization of lymphocyte antibody binding capacity - a multi-centre studyD Barnett, I Storie, V Granger, et al.
Journal of Immunological Methods|November 1, 2001
Affordable CD4+ T cell counts by flow cytometry. II. The use of fixed whole blood in resource-poor settingsV Jani, G Janossy, A Iqbal, et al.
British Journal of Haematology|November 25, 2000
FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk groupF M Abu-Duhier, A C Goodeve, G A Wilson, et al.
British Journal of Haematology|September 1, 1999
The management of 'low-risk' and 'intermediate-risk' patients with primary thrombocythaemia. MPD (UK) Study GroupT C Pearson, D Bareford, J Craig, et al.
British Journal of Haematology|July 21, 2005
Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosisMary F McMullin, D Bareford, P Campbell, et al.
British Journal of Haematology|September 1, 1996
Intermediate-dose busulphan before autografting for advanced-phase chronic myeloid leukaemiaS A Rule, D G Savage, S G O'Brien, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
British Journal of Haematology|March 11, 2004
Mutations in PTPN11 are uncommon in adult myelodysplastic syndromes and acute myeloid leukaemiaM F Johan, D T Bowen, M E Frew, et al.
British Journal of Haematology|June 19, 2001
Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patientsE Matutes, G P Taylor, J Cavenagh, et al.
Journal of Immunological Methods|January 4, 2005
Evaluation of leukocyte stabilisation in TransFix-treated blood samples by flow cytometry and transmission electron microscopyB Canonico, L Zamai, S Burattini, et al.
Hemoglobin|September 26, 2001
A second case of Hb Renert [beta133(H11)Val --> Ala]G Wilson, P Forrest, S Heppinstall, et al.
Clinical and Laboratory Haematology|May 3, 2000
Standardization of lymphocyte antibody binding capacity - a multi-centre studyD Barnett, I Storie, V Granger, et al.
Journal of Immunological Methods|November 1, 2001
Affordable CD4+ T cell counts by flow cytometry. II. The use of fixed whole blood in resource-poor settingsV Jani, G Janossy, A Iqbal, et al.
British Journal of Haematology|November 25, 2000
FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk groupF M Abu-Duhier, A C Goodeve, G A Wilson, et al.
British Journal of Haematology|September 1, 1999
The management of 'low-risk' and 'intermediate-risk' patients with primary thrombocythaemia. MPD (UK) Study GroupT C Pearson, D Bareford, J Craig, et al.
British Journal of Haematology|July 21, 2005
Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosisMary F McMullin, D Bareford, P Campbell, et al.
British Journal of Haematology|September 1, 1996
Intermediate-dose busulphan before autografting for advanced-phase chronic myeloid leukaemiaS A Rule, D G Savage, S G O'Brien, et al.
Pageof 10